New biologics offer hope for severe nasal polyps sufferers
NCT ID NCT06501807
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 900 adults with severe chronic sinusitis and nasal polyps who are taking biologic drugs. Researchers will track how these treatments affect quality of life, symptoms, and side effects over 5 years. The goal is to see which patients benefit most based on their health profile.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Lille
ACTIVE_NOT_RECRUITINGLille, France
-
chu de Lille
RECRUITINGLille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an asthma drug shrink nasal polyps? a major trial seeks answers
- Can a single drug shrink nasal polyps and restore breathing?
- Nanoparticle steroid spray could transform recovery after sinus surgery
- Could a single biologic replace steroid sprays for nasal polyps?
- Hot water rinse during sinus surgery may stop bleeding faster
- New injection could shrink nasal polyps without surgery